erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
.
advertisement
.
.
.
"in contrast, a mechanical mod is unregulated and works simply by drawing the power of a battery to an atomizer," he said.
.